Literature DB >> 17385690

Influence of HCV genotype and co-infection with human immunodeficiency virus on CD4(+) and CD8(+) T-cell responses to hepatitis C virus.

Laura Capa1, Vincent Soriano, Javier García-Samaniego, Marina Nuñez, Miriam Romero, Almudena Cascajero, Fernando Muñoz, Juan González-Lahoz, José M Benito.   

Abstract

The role of T-cells in clearance of hepatitis C virus (HCV) during acute infection is critical. The relevance of the immunological response in the control of HCV replication is less clear in chronic HCV infection. HCV-specific T-cell responses were examined in 92 interferon-naive individuals with chronic hepatitis C. A panel of 441 overlapping peptides spanning all expressed HCV proteins was used to measure HCV-specific T-cell responses, using flow cytometry after stimulating peripheral blood mononuclear cells (PBMCs) with different pools of these peptides. Most patients showed responses to at least one HCV protein, with NS5B for CD8(+) responses and E2 for CD4(+) responses identified most frequently. Both the prevalence and breadth of CD4(+) and CD8(+) responses were lower in co-infected patients, independently of the HCV genotype.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17385690     DOI: 10.1002/jmv.20856

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  8 in total

Review 1.  Coinfection with hepatitis C virus and human immunodeficiency virus: virological, immunological, and clinical outcomes.

Authors:  Yaron Rotman; T Jake Liang
Journal:  J Virol       Date:  2009-05-06       Impact factor: 5.103

2.  Interactions among co-infecting parasite species: a mechanism maintaining genetic variation in parasites?

Authors:  Otto Seppälä; Anssi Karvonen; E Tellervo Valtonen; Jukka Jokela
Journal:  Proc Biol Sci       Date:  2009-02-22       Impact factor: 5.349

Review 3.  Substance abuse, HIV-1 and hepatitis.

Authors:  Nirzari Parikh; Michael R Nonnemacher; Vanessa Pirrone; Timothy Block; Anand Mehta; Brian Wigdahl
Journal:  Curr HIV Res       Date:  2012-10       Impact factor: 1.581

4.  Soluble Fas and Fas ligand in HIV/HCV coinfected patients and impact of HCV therapy.

Authors:  M Guzmán-Fulgencio; J Berenguer; M García-Álvarez; D Micheloud; J C López; J Cosín; I Fernández de Castro; P Catalán; P Miralles; S Resino
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-03-26       Impact factor: 3.267

5.  Hepatitis C infection in HIV-1 natural viral suppressors.

Authors:  Mohammad M Sajadi; Nahzinine Shakeri; Rohit Talwani; Robert R Redfield
Journal:  AIDS       Date:  2010-07-17       Impact factor: 4.177

6.  Social determinants of health associated with hepatitis C co-infection among people living with HIV: results from the Positive Spaces, Healthy Places study.

Authors:  Sean B Rourke; Michael Sobota; Ruthann Tucker; Tsegaye Bekele; Katherine Gibson; Saara Greene; Colleen Price; J J Jay Koornstra; Laverne Monette; Steve Byers; James Watson; Stephen W Hwang; Dale Guenter; James Dunn; Amrita Ahluwalia; Michael G Wilson; Jean Bacon
Journal:  Open Med       Date:  2011-07-05

Review 7.  The natural history of early hepatitis C virus evolution; lessons from a global outbreak in human immunodeficiency virus-1-infected individuals.

Authors:  Emma C Thomson; Jennifer A Smith; Paul Klenerman
Journal:  J Gen Virol       Date:  2011-07-20       Impact factor: 3.891

8.  Complementary role of HCV and HIV in T-cell activation and exhaustion in HIV/HCV coinfection.

Authors:  Thijs Feuth; Joop E Arends; Justin H Fransen; Nening M Nanlohy; Karel J van Erpecum; Peter D Siersema; Andy I M Hoepelman; Debbie van Baarle
Journal:  PLoS One       Date:  2013-03-15       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.